9% w/v

DRUG2 trials

Sponsors

Hellenic Institute For The Study Of Sepsis, Medical University Of Vienna

Conditions

SEPSIScardiac arrestventricular fibrillation

Phase 2

EMAPALUMAB TREATMENT FOR ANTICIPATED CLINICAL BENEFIT IN SEPSIS DRIVEN BY THE INTERFERON-GAMMA ENDOTYPE (THE EMBRACE TRIAL)

Active, not recruitingCTIS2024-515255-38-00

Hellenic Institute For The Study Of SepsisSEPSIS

Start: 2025-03-12Target: 75Updated: 2025-11-03

Beta-blockade with landiolol in out-of-hospital cardiac arrest: a randomized, double-blind, placebo-controlled, pilot trial

RecruitingCTIS2024-518949-14-00

Medical University Of Viennacardiac arrest, ventricular fibrillation

Start: 2020-11-30Target: 48Updated: 2024-12-10